In the last 12 months, insiders at PepGen Inc. ($PEPG) filed 165 transactions with the SEC: 9 open-market purchases totaling $68,541,145 and 30 sales totaling $1,718,263. Net insider sentiment: net buying.
PepGen Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- RA CAPITAL MANAGEMENT, L.P. (Not found) — 3 transactions totaling $30,000,000
- RA CAPITAL MANAGEMENT, L.P. (Director) — 1 transaction totaling $27,212,790
- Oxford Science Enterprises plc (Not found) — 1 transaction totaling $10,559,640
- Mellion Michelle L (Chief Medical Officer) — 30 transactions totaling $1,171,357
- McArthur James G (President and CEO) — 40 transactions totaling $691,250
View all SEC Filings for PepGen Inc. (PEPG).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Donnelly Noel | Chief Financial Officer | S | Common Stock | 2032 | $6.23 | 111,655.0000 | 68,748,224 | 1.79% | 0.00% |
| March 4, 2026 | Donnelly Noel | Chief Financial Officer | S | Common Stock | 52 | $6.33 | 111,603.0000 | 68,748,224 | 0.05% | 0.00% |
| March 4, 2026 | McArthur James G | President and CEO | S | Common Stock | 5144 | $6.23 | 296,457.0000 | 68,748,224 | 1.71% | 0.01% |
| March 4, 2026 | McArthur James G | President and CEO | S | Common Stock | 131 | $6.33 | 296,326.0000 | 68,748,224 | 0.04% | 0.00% |
| March 4, 2026 | STRECK PAUL | EVP, Head of R&D | S | Common Stock | 1832 | $6.23 | 76,273.0000 | 68,748,224 | 2.35% | 0.00% |
| March 4, 2026 | STRECK PAUL | EVP, Head of R&D | S | Common Stock | 47 | $6.29 | 76,226.0000 | 68,748,224 | 0.06% | 0.00% |
| March 1, 2026 | Kasraian Kasra | Chief Technical Officer | A | Common Stock | 34557 | $0.00 | 51,307.0000 | 68,748,224 | 206.31% | 0.05% |
| March 1, 2026 | Kasraian Kasra | Chief Technical Officer | A | Stock Option (Right to Buy) | 135000 | $0.00 | 135,000.0000 | 68,748,224 | 9999.99% | 0.20% |
| March 1, 2026 | STRECK PAUL | EVP, Head of R&D | A | Common Stock | 50300 | $0.00 | 78,105.0000 | 68,748,224 | 180.90% | 0.07% |
| March 1, 2026 | STRECK PAUL | EVP, Head of R&D | A | Stock Option (Right to Buy) | 196500 | $0.00 | 196,500.0000 | 68,748,224 | 9999.99% | 0.29% |
| March 1, 2026 | Donnelly Noel | Chief Financial Officer | A | Common Stock | 76793 | $0.00 | 113,687.0000 | 68,748,224 | 208.15% | 0.11% |
| March 1, 2026 | Donnelly Noel | Chief Financial Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 68,748,224 | 9999.99% | 0.44% |
| March 1, 2026 | McArthur James G | President and CEO | A | Common Stock | 187688 | $0.00 | 301,601.0000 | 68,748,224 | 164.76% | 0.27% |
| March 1, 2026 | McArthur James G | President and CEO | A | Stock Option (Right to Buy) | 731250 | $0.00 | 731,250.0000 | 68,748,224 | 9999.99% | 1.06% |
| March 1, 2026 | Vittiglio Joseph | Chief Business & Legal Officer | A | Common Stock | 30717 | $0.00 | 65,717.0000 | 68,748,224 | 87.76% | 0.04% |
| March 1, 2026 | Vittiglio Joseph | Chief Business & Legal Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 68,748,224 | 9999.99% | 0.17% |
| Nov. 4, 2025 | McArthur James G | President and CEO | D | Stock Option (Right to Buy) | 352705 | $0.00 | 0.0000 | 32,692,388 | 100.00% | 1.08% |
| Nov. 4, 2025 | STRECK PAUL | EVP, Head of R&D | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 32,692,388 | 100.00% | 0.12% |
| Nov. 4, 2025 | STRECK PAUL | EVP, Head of R&D | A | Stock Option (Right to Buy) | 202816 | $0.00 | 202,816.0000 | 32,692,388 | 9999.99% | 0.62% |
| Nov. 4, 2025 | STRECK PAUL | EVP, Head of R&D | D | Stock Option (Right to Buy) | 202816 | $0.00 | 40,000.0000 | 32,692,388 | 83.53% | 0.62% |
| Nov. 4, 2025 | Donnelly Noel | Chief Financial Officer | D | Stock Option (Right to Buy) | 169037 | $0.00 | 0.0000 | 32,692,388 | 100.00% | 0.52% |
| Nov. 4, 2025 | Donnelly Noel | Chief Financial Officer | A | Stock Option (Right to Buy) | 203339 | $0.00 | 203,339.0000 | 32,692,388 | 9999.99% | 0.62% |
| Nov. 4, 2025 | Donnelly Noel | Chief Financial Officer | D | Stock Option (Right to Buy) | 203339 | $0.00 | 0.0000 | 32,692,388 | 100.00% | 0.62% |
| Nov. 4, 2025 | McArthur James G | President and CEO | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 32,692,388 | 9999.99% | 0.92% |
| Nov. 4, 2025 | McArthur James G | President and CEO | D | Stock Option (Right to Buy) | 300000 | $0.00 | 0.0000 | 32,692,388 | 100.00% | 0.92% |
| Nov. 4, 2025 | McArthur James G | President and CEO | A | Stock Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 32,692,388 | 9999.99% | 0.84% |
| Nov. 4, 2025 | McArthur James G | President and CEO | D | Stock Option (Right to Buy) | 275000 | $0.00 | 0.0000 | 32,692,388 | 100.00% | 0.84% |
| Nov. 4, 2025 | McArthur James G | President and CEO | A | Stock Option (Right to Buy) | 466095 | $0.00 | 466,095.0000 | 32,692,388 | 9999.99% | 1.43% |
| Nov. 4, 2025 | McArthur James G | President and CEO | D | Stock Option (Right to Buy) | 466095 | $0.00 | 0.0000 | 32,692,388 | 100.00% | 1.43% |
| Nov. 4, 2025 | McArthur James G | President and CEO | A | Stock Option (Right to Buy) | 40815 | $0.00 | 40,815.0000 | 32,692,388 | 9999.99% | 0.12% |
| Nov. 4, 2025 | McArthur James G | President and CEO | D | Stock Option (Right to Buy) | 40815 | $0.00 | 0.0000 | 32,692,388 | 100.00% | 0.12% |
| Nov. 4, 2025 | McArthur James G | President and CEO | A | Stock Option (Right to Buy) | 40815 | $0.00 | 40,815.0000 | 32,692,388 | 9999.99% | 0.12% |
| Nov. 4, 2025 | McArthur James G | President and CEO | D | Stock Option (Right to Buy) | 40815 | $0.00 | 0.0000 | 32,692,388 | 100.00% | 0.12% |
| Nov. 4, 2025 | McArthur James G | President and CEO | A | Stock Option (Right to Buy) | 40815 | $0.00 | 40,815.0000 | 32,692,388 | 9999.99% | 0.12% |
| Nov. 4, 2025 | McArthur James G | President and CEO | D | Stock Option (Right to Buy) | 40815 | $0.00 | 0.0000 | 32,692,388 | 100.00% | 0.12% |
| Nov. 4, 2025 | McArthur James G | President and CEO | A | Stock Option (Right to Buy) | 352705 | $0.00 | 352,705.0000 | 32,692,388 | 9999.99% | 1.08% |
| Nov. 4, 2025 | STRECK PAUL | EVP, Head of R&D | A | Stock Option (Right to Buy) | 40000 | $0.00 | 242,816.0000 | 32,692,388 | 19.72% | 0.12% |
| Nov. 4, 2025 | Donnelly Noel | Chief Financial Officer | A | Stock Option (Right to Buy) | 144000 | $0.00 | 144,000.0000 | 32,692,388 | 9999.99% | 0.44% |
| Nov. 4, 2025 | Donnelly Noel | Chief Financial Officer | D | Stock Option (Right to Buy) | 144000 | $0.00 | 0.0000 | 32,692,388 | 100.00% | 0.44% |
| Nov. 4, 2025 | Donnelly Noel | Chief Financial Officer | A | Stock Option (Right to Buy) | 144000 | $0.00 | 144,000.0000 | 32,692,388 | 9999.99% | 0.44% |
| Nov. 4, 2025 | Donnelly Noel | Chief Financial Officer | D | Stock Option (Right to Buy) | 144000 | $0.00 | 0.0000 | 32,692,388 | 100.00% | 0.44% |
| Nov. 4, 2025 | Donnelly Noel | Chief Financial Officer | A | Stock Option (Right to Buy) | 169037 | $0.00 | 169,037.0000 | 32,692,388 | 9999.99% | 0.52% |
| Dec. 8, 2025 | Vittiglio Joseph | Chief Business & Legal Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 68,748,224 | 9999.99% | 0.23% |
| Dec. 8, 2025 | Vittiglio Joseph | Chief Business & Legal Officer | A | Common Stock | 35000 | $0.00 | 35,000.0000 | 68,748,224 | 9999.99% | 0.05% |
| Sept. 30, 2025 | Oxford Science Enterprises plc | Other | P | Common Stock | 200000 | $3.20 | 4,955,388.0000 | 32,692,388 | 4.21% | 0.61% |
| Sept. 26, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 9375000 | $3.20 | 20,064,545.0000 | 32,692,388 | 87.70% | 28.68% |
| June 4, 2025 | HENSON HEIDI | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 32,692,388 | 9999.99% | 0.05% |
| June 4, 2025 | Mayer Howard | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 32,692,388 | 9999.99% | 0.05% |
| June 4, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 32,692,388 | 9999.99% | 0.05% |
| June 4, 2025 | Resnick Joshua | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 32,692,388 | 9999.99% | 0.05% |
| June 4, 2025 | Dable Habib J | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 32,692,388 | 9999.99% | 0.05% |
| June 4, 2025 | KEATING LAURIE | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 32,692,388 | 9999.99% | 0.05% |
| May 30, 2025 | STRECK PAUL | EVP, Head of R&D | P | Common Stock | 8375 | $1.24 | 27,805.0000 | 32,692,388 | 43.10% | 0.03% |
| May 20, 2025 | Kasraian Kasra | Chief Technical Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 32,692,388 | 9999.99% | 0.23% |
| May 20, 2025 | Kasraian Kasra | Chief Technical Officer | A | Common Stock | 16750 | $0.00 | 16,750.0000 | 32,692,388 | 9999.99% | 0.05% |
| April 17, 2025 | McArthur James G | President and CEO | P | Common Stock | 10000 | $1.36 | 113,913.0000 | 32,692,388 | 9.62% | 0.03% |
| April 8, 2025 | McArthur James G | President and CEO | P | Common Stock | 41500 | $1.15 | 103,913.0000 | 32,692,388 | 66.49% | 0.13% |
| March 27, 2025 | Finer Mitchell H. | Director | A | Stock Option (Right to Buy) | 26000 | $0.00 | 26,000.0000 | 32,692,388 | 9999.99% | 0.08% |
| March 27, 2025 | Wyman Lisa | Director | A | Stock Option (Right to Buy) | 26000 | $0.00 | 26,000.0000 | 32,692,388 | 9999.99% | 0.08% |
| March 3, 2025 | McArthur James G | President and CEO | A | Stock Option (Right to Buy) | 271875 | $0.00 | 271,875.0000 | 32,692,388 | 9999.99% | 0.83% |
| March 3, 2025 | DeLena Mary Beth | General Counsel | A | Common Stock | 13400 | $0.00 | 14,968.0000 | 32,692,388 | 854.59% | 0.04% |
| March 3, 2025 | DeLena Mary Beth | General Counsel | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 32,692,388 | 9999.99% | 0.18% |
| March 3, 2025 | Donnelly Noel | Chief Financial Officer | A | Common Stock | 23283 | $0.00 | 24,956.0000 | 32,692,388 | 1391.69% | 0.07% |
| March 3, 2025 | Donnelly Noel | Chief Financial Officer | A | Stock Option (Right to Buy) | 104250 | $0.00 | 104,250.0000 | 32,692,388 | 9999.99% | 0.32% |
| March 3, 2025 | STRECK PAUL | EVP, Head of R&D | A | Common Stock | 19430 | $0.00 | 19,430.0000 | 32,692,388 | 9999.99% | 0.06% |
| March 3, 2025 | STRECK PAUL | EVP, Head of R&D | A | Stock Option (Right to Buy) | 87000 | $0.00 | 87,000.0000 | 32,692,388 | 9999.99% | 0.27% |
| March 3, 2025 | McArthur James G | President and CEO | A | Common Stock | 60719 | $0.00 | 62,413.0000 | 32,692,388 | 3584.36% | 0.19% |
| Feb. 26, 2025 | DeLena Mary Beth | General Counsel | S | Common Stock | 1432 | $1.68 | 1,568.0000 | 32,692,388 | 47.73% | 0.00% |
| Feb. 24, 2025 | Donnelly Noel | Chief Financial Officer | A | Common Stock | 3200 | $0.00 | 3,200.0000 | 32,692,388 | 9999.99% | 0.01% |
| Feb. 26, 2025 | Donnelly Noel | Chief Financial Officer | S | Common Stock | 1527 | $1.68 | 1,673.0000 | 32,692,388 | 47.72% | 0.00% |
| Feb. 24, 2025 | DeLena Mary Beth | General Counsel | A | Common Stock | 3000 | $0.00 | 3,000.0000 | 32,692,388 | 9999.99% | 0.01% |
| Aug. 19, 2024 | STRECK PAUL | EVP, Head of R&D | A | Stock Option (Right to Buy) | 40000 | $0.00 | 242,816.0000 | 0 | 19.72% | 0.00% |
| Aug. 19, 2024 | STRECK PAUL | EVP, Head of R&D | A | Stock Option (Right to Buy) | 202816 | $0.00 | 202,816.0000 | 0 | 9999.99% | 0.00% |
| July 25, 2024 | Mellion Michelle L | Chief Medical Officer | S | Common Stock | 7571 | $18.06 | 0.0000 | 0 | 100.00% | 0.00% |
| July 25, 2024 | Mellion Michelle L | Chief Medical Officer | M | Common Stock | 7571 | $10.21 | 7,571.0000 | 0 | 9999.99% | 0.00% |
| July 24, 2024 | Mellion Michelle L | Chief Medical Officer | S | Common Stock | 201 | $18.01 | 0.0000 | 0 | 100.00% | 0.00% |
| July 24, 2024 | Mellion Michelle L | Chief Medical Officer | M | Common Stock | 201 | $10.21 | 201.0000 | 0 | 9999.99% | 0.00% |
| July 25, 2024 | Mellion Michelle L | Chief Medical Officer | M | Stock Option (Right to Buy) | 7571 | $0.00 | 50,000.0000 | 0 | 13.15% | 0.00% |
| July 24, 2024 | Mellion Michelle L | Chief Medical Officer | M | Stock Option (Right to Buy) | 201 | $0.00 | 57,571.0000 | 0 | 0.35% | 0.00% |
| July 18, 2024 | Mellion Michelle L | Chief Medical Officer | M | Common Stock | 12625 | $10.21 | 12,625.0000 | 0 | 9999.99% | 0.00% |
| July 18, 2024 | Mellion Michelle L | Chief Medical Officer | M | Stock Option (Right to Buy) | 12625 | $0.00 | 57,772.0000 | 0 | 17.93% | 0.00% |
| July 18, 2024 | Mellion Michelle L | Chief Medical Officer | S | Common Stock | 12625 | $18.20 | 0.0000 | 0 | 100.00% | 0.00% |
| July 12, 2024 | Mellion Michelle L | Chief Medical Officer | M | Common Stock | 3288 | $10.21 | 3,288.0000 | 0 | 9999.99% | 0.00% |
| July 16, 2024 | Mellion Michelle L | Chief Medical Officer | M | Stock Option (Right to Buy) | 5901 | $0.00 | 70,397.0000 | 0 | 7.73% | 0.00% |
| July 12, 2024 | Mellion Michelle L | Chief Medical Officer | M | Stock Option (Right to Buy) | 3288 | $0.00 | 76,298.0000 | 0 | 4.13% | 0.00% |
| July 16, 2024 | Mellion Michelle L | Chief Medical Officer | S | Common Stock | 5901 | $18.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 16, 2024 | Mellion Michelle L | Chief Medical Officer | M | Common Stock | 5901 | $10.21 | 5,901.0000 | 0 | 9999.99% | 0.00% |
| July 12, 2024 | Mellion Michelle L | Chief Medical Officer | S | Common Stock | 3288 | $18.04 | 0.0000 | 0 | 100.00% | 0.00% |
| July 1, 2024 | Mellion Michelle L | Chief Medical Officer | M | Common Stock | 875 | $10.21 | 875.0000 | 0 | 9999.99% | 0.00% |
| July 2, 2024 | Mellion Michelle L | Chief Medical Officer | M | Common Stock | 37 | $10.21 | 37.0000 | 0 | 9999.99% | 0.00% |
| July 2, 2024 | Mellion Michelle L | Chief Medical Officer | S | Common Stock | 37 | $18.07 | 0.0000 | 0 | 100.00% | 0.00% |
| July 1, 2024 | Mellion Michelle L | Chief Medical Officer | M | Stock Option (Right to Buy) | 875 | $0.00 | 79,623.0000 | 0 | 1.09% | 0.00% |
| July 2, 2024 | Mellion Michelle L | Chief Medical Officer | M | Stock Option (Right to Buy) | 37 | $0.00 | 79,586.0000 | 0 | 0.05% | 0.00% |
| July 1, 2024 | Mellion Michelle L | Chief Medical Officer | S | Common Stock | 875 | $18.01 | 0.0000 | 0 | 100.00% | 0.00% |
| June 24, 2024 | Mellion Michelle L | Chief Medical Officer | S | Common Stock | 9260 | $18.19 | 0.0000 | 0 | 100.00% | 0.00% |
| June 24, 2024 | Mellion Michelle L | Chief Medical Officer | M | Stock Option (Right to Buy) | 9260 | $0.00 | 80,498.0000 | 0 | 10.32% | 0.00% |
| June 24, 2024 | Mellion Michelle L | Chief Medical Officer | M | Common Stock | 9260 | $10.21 | 9,260.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Mayer Howard | Director | A | Stock Option (Right to Buy) | 8667 | $0.00 | 8,667.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | HENSON HEIDI | Director | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | KEATING LAURIE | Director | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Resnick Joshua | Director | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Ashton Christopher | Director | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Dable Habib J | Director | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Mellion Michelle L | Chief Medical Officer | S | Common Stock | 1086 | $18.06 | 0.0000 | 0 | 100.00% | 0.00% |
| June 11, 2024 | Mellion Michelle L | Chief Medical Officer | M | Common Stock | 500 | $10.21 | 500.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Mellion Michelle L | Chief Medical Officer | S | Common Stock | 500 | $18.04 | 0.0000 | 0 | 100.00% | 0.00% |
| June 12, 2024 | Mellion Michelle L | Chief Medical Officer | M | Stock Option (Right to Buy) | 1086 | $0.00 | 89,758.0000 | 0 | 1.20% | 0.00% |
| June 11, 2024 | Mellion Michelle L | Chief Medical Officer | M | Stock Option (Right to Buy) | 500 | $0.00 | 90,844.0000 | 0 | 0.55% | 0.00% |
| June 12, 2024 | Mellion Michelle L | Chief Medical Officer | M | Common Stock | 1086 | $10.21 | 1,086.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Mellion Michelle L | SVP, Clinical Development | M | Stock Option (Right to Buy) | 1411 | $0.00 | 91,344.0000 | 0 | 1.52% | 0.00% |
| June 5, 2024 | Mellion Michelle L | SVP, Clinical Development | M | Common Stock | 7245 | $10.21 | 7,245.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Mellion Michelle L | SVP, Clinical Development | M | Common Stock | 1411 | $10.21 | 1,411.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Mellion Michelle L | SVP, Clinical Development | M | Stock Option (Right to Buy) | 7245 | $0.00 | 92,755.0000 | 0 | 7.25% | 0.00% |
| June 6, 2024 | Mellion Michelle L | SVP, Clinical Development | S | Common Stock | 1411 | $18.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 5, 2024 | Mellion Michelle L | SVP, Clinical Development | S | Common Stock | 7245 | $18.09 | 0.0000 | 0 | 100.00% | 0.00% |
| May 17, 2024 | Svenstrup Niels | SVP, Chem. Mfg & Controls | S | Common Stock | 10000 | $13.41 | 0.0000 | 0 | 100.00% | 0.00% |
| May 10, 2022 | Oxford Science Enterprises plc | Not found | P | Common Stock | 879970 | $12.00 | 4,755,388.0000 | 0 | 22.71% | 0.00% |
| March 1, 2024 | Mellion Michelle L | SVP, Clinical Development | A | Stock Option (Right to Buy) | 83000 | $0.00 | 83,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Donnelly Noel | Chief Financial Officer | A | Stock Option (Right to Buy) | 144000 | $0.00 | 144,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | McArthur James G | President and CEO | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Svenstrup Niels | SVP, Chem. Mfg & Controls | A | Stock Option (Right to Buy) | 83000 | $0.00 | 83,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 2557593 | $10.64 | 10,689,545.0000 | 0 | 31.45% | 0.00% |
| Jan. 15, 2024 | DeLena Mary Beth | General Counsel | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 30, 2023 | McArthur James G | President and CEO | P | Common Stock | 1694 | $4.17 | 1,694.0000 | 0 | 9999.99% | 0.00% |
| Nov. 10, 2023 | Mayer Howard | Director | A | Stock Option (Right to Buy) | 22686 | $0.00 | 22,686.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | Dable Habib J | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | Ashton Christopher | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | Resnick Joshua | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | KEATING LAURIE | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | HENSON HEIDI | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | McArthur James G | President and CEO | S | Common Stock | 2381 | $16.04 | 0.0000 | 0 | 100.00% | 0.00% |
| June 8, 2023 | McArthur James G | President and CEO | M | Common Stock | 2381 | $2.71 | 2,381.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | McArthur James G | President and CEO | M | Stock Option (Right to Buy) | 2381 | $0.00 | 325,054.0000 | 0 | 0.73% | 0.00% |
| June 6, 2023 | McArthur James G | President and CEO | M | Stock Option (Right to Buy) | 18150 | $0.00 | 335,854.0000 | 0 | 5.13% | 0.00% |
| June 6, 2023 | McArthur James G | President and CEO | M | Common Stock | 18150 | $2.71 | 18,150.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | McArthur James G | President and CEO | S | Common Stock | 18150 | $16.18 | 0.0000 | 0 | 100.00% | 0.00% |
| June 7, 2023 | McArthur James G | President and CEO | M | Common Stock | 8419 | $2.71 | 8,419.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | McArthur James G | President and CEO | S | Common Stock | 8419 | $16.23 | 0.0000 | 0 | 100.00% | 0.00% |
| June 7, 2023 | McArthur James G | President and CEO | M | Stock Option (Right to Buy) | 8419 | $0.00 | 327,435.0000 | 0 | 2.51% | 0.00% |
| June 2, 2023 | McArthur James G | President and CEO | M | Stock Option (Right to Buy) | 1800 | $0.00 | 354,504.0000 | 0 | 0.51% | 0.00% |
| June 5, 2023 | McArthur James G | President and CEO | M | Stock Option (Right to Buy) | 500 | $0.00 | 354,004.0000 | 0 | 0.14% | 0.00% |
| June 5, 2023 | McArthur James G | President and CEO | S | Common Stock | 500 | $16.06 | 0.0000 | 0 | 100.00% | 0.00% |
| June 5, 2023 | McArthur James G | President and CEO | M | Common Stock | 500 | $2.71 | 500.0000 | 0 | 9999.99% | 0.00% |
| June 2, 2023 | McArthur James G | President and CEO | S | Common Stock | 1800 | $16.04 | 0.0000 | 0 | 100.00% | 0.00% |
| June 2, 2023 | McArthur James G | President and CEO | M | Common Stock | 1800 | $2.71 | 1,800.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | S | Common Stock | 392 | $20.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | M | Common Stock | 392 | $10.88 | 392.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | M | Stock Option (Right to Buy) | 392 | $0.00 | 143,804.0000 | 0 | 0.27% | 0.00% |
| March 1, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Svenstrup Niels | SVP, Chem. Mfg & Controls | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Donnelly Noel | Chief Financial Officer | A | Stock Option (Right to Buy) | 144000 | $0.00 | 144,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | McArthur James G | President and CEO | A | Stock Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Mellion Michelle L | SVP, Clinical Development | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Mellion Michelle L | SVP, Clinical Development | A | Stock Option (Right to Buy) | 20000 | $0.00 | 95,000.0000 | 0 | 26.67% | 0.00% |
| Feb. 8, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | S | Common Stock | 644 | $17.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | M | Stock Option (Right to Buy) | 1677 | $0.00 | 148,519.0000 | 0 | 1.12% | 0.00% |
| Feb. 7, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | M | Stock Option (Right to Buy) | 3679 | $0.00 | 144,840.0000 | 0 | 2.48% | 0.00% |
| Feb. 8, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | M | Stock Option (Right to Buy) | 644 | $0.00 | 144,196.0000 | 0 | 0.44% | 0.00% |
| Feb. 6, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | M | Common Stock | 1677 | $10.88 | 1,677.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | S | Common Stock | 1677 | $17.04 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 7, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | M | Common Stock | 3679 | $10.88 | 3,679.0000 | 0 | 9999.99% | 0.00% |
| Feb. 7, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | S | Common Stock | 3679 | $17.18 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 8, 2023 | Goyal Jaya | EVP, Res. & Preclin. Dev. | M | Common Stock | 644 | $10.88 | 644.0000 | 0 | 9999.99% | 0.00% |
| May 6, 2022 | KEATING LAURIE | Director | P | Common Stock | 4166 | $12.00 | 4,166.0000 | 0 | 9999.99% | 0.00% |